Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma

by Di Wang, Kai Sun, Tianqi Wang, Dongxu Zhang, Fengze Sun, Yuanshan Cui, Hongwei Zhao, Jitao Wu
Published 2021

The Efficacy and Safety of Mirabegron for the Treatment of Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Meta-analysis

by Dongxu Zhang, Fengze Sun, Huibao Yao, Xingjun Bao, Di Wang, Yuanshan Cui, Yuanshan Cui, Jitao Wu
Published 2021

Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin

by Fengze Sun, Yuanyuan Liu, Tingting Gong, Qiuzhong Pan, Tong Xiang, Jingjing Zhao, Yan Tang, Hao Chen, Yulong Han, Mengjia Song, Yue Huang, Han Li, Yuanyuan Chen, Chaopin Yang, Jieying Yang, Qijing Wang, Yongqiang Li, Jia He, Desheng Weng, Ruiqing Peng, Jianchuan Xia
Published 2021